arrow
M

Michelle L. Sever

ppd
H指数:27
被引数:5,521

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Protocol design for the ACTIVATE clinical trial: Exposure to vaginal microbiome in cesarean-delivered infants at high risk for allergies

ACTIVATE临床试验的方案设计:对具有过敏高风险的剖宫产婴儿暴露于阴道微生物群的研究

2025-09-010
OAAI
Donor-specific mesenchymal stem cell infusion in human and nonhuman primate kidney transplantation

供者特异性间充质干细胞输注在人类和非人灵长类动物肾移植中的应用

2025-05-120
PRE
Developing a Prediction Model for Determination of Peanut Allergy Status in the Learning Early About Peanut Allergy (LEAP) Studies

在早期了解花生过敏 (LEAP) 研究中开发用于确定花生过敏状态的预测模型

2023-07-015
OAAI
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial

特泽帕鲁单抗联合过敏原免疫疗法对鼻腔过敏原反应的影响:一项随机对照试验

2023-01-0138
OAAI
Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study

肺移植后急性肺损伤和组织肺炎的预后意义和临床危险因素: 来自多中心前瞻性队列研究的数据

2022-12-017
OA
Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study
2021-10-016
OAAI
Development of nasal allergen challenge with cockroach in children with asthma

蟑螂对哮喘儿童鼻过敏原激发的发展

2021-03-203
OAAI
Risk Factors for Acute Rejection in the First Year after Lung Transplant A Multicenter Study

肺移植后第一年急性排斥反应的危险因素: 一项多中心研究

2020-08-1541
OAAI
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen

鼻过敏原挑战和环境暴露室挑战: 一项比较对猫过敏原的临床和生物学反应的随机试验

2020-06-0132
OAAI
Occurrence and Risk Factors for Acute Lung Injury (ALI) and Organizing Pneumonia (OP) after Lung Transplant
2019-04-010
PREAI
Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort

花生过敏研究队列中早期食用花生的过敏原特异性及其对过敏性疾病发展的影响

2018-04-0188
OAAI
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis The GRASS Randomized Clinical Trial
2017-02-14164
OAAI